Nasus Pharma is trading $3.97 (+6.37%) after announcing management’s presentation at the H.C. Wainwright 28th Annual Global Investment Conference.

  • The announcement was made on September 8, 2026; the conference runs September 14–16.
  • The presentation will be available online beginning September 11, with investor meetings also scheduled.
  • Trading remains relatively light, so limited liquidity and positioning ahead of the conference may amplify the move.